BioSpace News Archive

Business

Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results

Zymeworks Inc. (Nasdaq: ZYME) today reported financial results for the fourth quarter and year ended December 31, 2023, and provided a summary of recent business highlights.

March 6, 2024
·
25 min read
Bio NC

IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024

IQVIA Holdings Inc., announced that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays 26th Annual Global Healthcare Conference in Miami on Wednesday, March 13, 2024 at 9:30 a.m. ET.

March 6, 2024
·
1 min read
Biotech Bay

Protagonist Therapeutics to Participate in Upcoming March 2024 Investor Conferences

Protagonist Therapeutics, Inc. announced that they will participate in three upcoming investor conferences.

March 6, 2024
·
2 min read
Genetown

Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024

Disc Medicine, Inc. (NASDAQ:IRON) announced today that company management will participate in a fireside chat at the Leerink Partners Global Biopharma Conference 2024 on Monday, March 11th at 10:40 am ET.

March 6, 2024
·
1 min read
Drug Development

MediPrint® Ophthalmics Announces Successful Completion of Its Phase 2b Glaucoma Clinical Study with Positive Results.

MediPrint® Ophthalmics, a clinical-stage ocular drug delivery platform technology focused on transforming ocular drug delivery, announces the completion of its Glaucoma SIGHT-2, Phase 2b study.

March 6, 2024
·
3 min read
Business

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results

MDxHealth SA, a commercial-stage precision diagnostics company, announced its financial results for the fourth quarter and year ended December 31, 2023.

March 6, 2024
·
13 min read
Pharm Country

Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference

Larimar Therapeutics, Inc. announced that members of the company’s management team will present and participate in 1x1 investor meetings at the Leerink Partners Global Biopharma Conference, taking place in Miami Beach, FL from March 11 – 13, 2024.

March 6, 2024
·
1 min read
Business

PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments

PepGen Inc. (Nasdaq: PEPG) today reported financial results for the fourth quarter and full year ended December 31, 2023, and highlighted recent corporate developments.

March 6, 2024
·
11 min read
Genetown

Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences - March 06, 2024

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, announced that the Company will participate in two upcoming investor conferences.

March 6, 2024
·
7 min read
Genetown

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 06, 2024

Apellis Pharmaceuticals, Inc. announced that the company approved the grant of equity awards to one new employee with a grant date of March 1, 2024, as equity inducement awards outside of the company’s 2017 Stock Incentive Plan and material to the employees’ acceptance of employment with the company.

March 6, 2024
·
2 min read